Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
US FDA Observation
|
Mid-range Performer
1660.4000
7.20
(
0.44
%)
NSE
Jun 18, 2025
15:31 PM
38.45% Gain from 52W Low
Volume:
990.4K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
17 Nov 2022, 12:00AM
US FDA Observation
1660.40
0.44%
Working on many fronts to better outlook and return ratios
Neutral:
Glenmark Pharmaceuticals Ltd.
by
Motilal Oswal
Target: 420
Motilal Oswal
Glenmark Pharmaceuti.. has an
average target
of 1662.25 from 5 brokers.
More from Glenmark Pharmaceuticals Ltd.
Recommended
Chart of the Week: Profit booking grips promoters as stake sales surge across sectors
The Baseline |
18 Jun 2025, 05:06PM
Market closes lower, HDFC Bank CEO challenges FIR over disputed loan disclosure
Trendlyne Marketwatch |
18 Jun 2025, 03:58PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020